Difference between revisions of "Levamisole (Ergamisol)"
Jump to navigation
Jump to search
m |
m |
||
| (4 intermediate revisions by the same user not shown) | |||
| Line 4: | Line 4: | ||
*[[Breast cancer - historical|Breast cancer]] | *[[Breast cancer - historical|Breast cancer]] | ||
==History of changes in FDA indication== | ==History of changes in FDA indication== | ||
| − | * | + | *1990-06-18: indicated as adjuvant treatment in combination with [[Fluorouracil (5-FU)|5-fluorouracil]] after surgical resection in patients with Dukes' stage C [[colon cancer]]. ''(Based on Laurie et al. 1989 & SWOG S8591)'' |
| + | ==History of changes in EMA indication== | ||
| + | *1966-06-14: EURD | ||
==Also known as== | ==Also known as== | ||
| Line 11: | Line 13: | ||
[[Category:Oral medications]] | [[Category:Oral medications]] | ||
| + | [[Category:Antihelminthic]] | ||
[[Category:Breast cancer medications (historic)]] | [[Category:Breast cancer medications (historic)]] | ||
[[Category:Colon cancer medications (historic)]] | [[Category:Colon cancer medications (historic)]] | ||
[[Category:FDA approved in 1990]] | [[Category:FDA approved in 1990]] | ||
| + | [[Category:EMA approved in 1966]] | ||
[[Category:Discontinued drugs]] | [[Category:Discontinued drugs]] | ||
Latest revision as of 10:37, 4 July 2023
This agent is not commercially available in the United States and is included for historic purposes only.
Diseases for which it was used
History of changes in FDA indication
- 1990-06-18: indicated as adjuvant treatment in combination with 5-fluorouracil after surgical resection in patients with Dukes' stage C colon cancer. (Based on Laurie et al. 1989 & SWOG S8591)
History of changes in EMA indication
- 1966-06-14: EURD
Also known as
- Brand name: Ergamisol